Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
Kalkine: Indivior to Exit London Exchange, Retain Nasdaq Listing Status – indexftse ukx Impact
Healthcare Stocks

Kalkine: Indivior to Exit London Exchange, Retain Nasdaq Listing Status – indexftse ukx Impact

Highlights,Indivior PLC to delist from the London Stock Exchange while maintaining its Nasdaq listing,The pharmaceutical company will continue to trade under ticker INDV on Nasdaq,Delisting marks a shift in listing strategy, with the firm’s primary focus ...

Kalkine: Schroders (LON:SDR) shares show upward trend despite long-term decline, reflecting sentiment shift in indexftse ukx
Market updates

Kalkine: Schroders (LON:SDR) shares show upward trend despite long-term decline, reflecting sentiment shift in indexftse ukx

Highlights,Schroders plc (LON:SDR) has shown recent upward share price movement despite a multi-year downward trend,Earnings per share declined at a slower rate than the share price over the same period,Sentiment around the financial sector stock within t...

Kalkine UK Market Movers: Vodafone, Indivior, ME Group Shift Momentum | indexftse ukx
Market updates

Kalkine UK Market Movers: Vodafone, Indivior, ME Group Shift Momentum | indexftse ukx

Highlights,Vodafone (LON:VOD) completes Three UK merger, restructuring European operations,Indivior (LON:INDV) to exit London Stock Exchange, focusing on Nasdaq listing,ME Group (LON:MEGP) reports strong laundry business performance in trading update,Voda...

Kalkine: Indivior Exits London Listing Amid Cost Strategy Shift | indexftse ukx
Market updates

Kalkine: Indivior Exits London Listing Amid Cost Strategy Shift | indexftse ukx

Highlights,Pharmaceutical group Indivior PLC (LON:INDV) confirms withdrawal from the London Stock Exchange,The company will maintain its sole listing on the Nasdaq stock exchange,The move comes as a strategic step focused on streamlining operations and re...

Kalkine: Indivior Plans London Exit, Maintains Nasdaq Listing Amid Strategic Shift in FTSE 350 Healthcare Space
Market updates

Kalkine: Indivior Plans London Exit, Maintains Nasdaq Listing Amid Strategic Shift in FTSE 350 Healthcare Space

Highlights,Indivior announces its intention to delist from the London Stock Exchange,The company will retain its primary listing on the Nasdaq under ticker INDV,London delisting aligns with Indivior's geographic revenue concentration and trading volumes,I...

Kalkine: FTSE 350 pharma firm (LSE:INDV) exits LSE for Nasdaq focus
Healthcare Stocks

Kalkine: FTSE 350 pharma firm (LSE:INDV) exits LSE for Nasdaq focus

Highlights,FTSE 350 pharmaceutical company INDV.L confirms exit from London Stock Exchange,INDV.L to prioritise Nasdaq GS as its sole primary listing moving forward,Majority of INDV.L shareholders and trading activity now based in the United States,FTSE 3...

kalkine: FTSE 350 firm Indivior PLC (LON:INDV) to leave London listing after Nasdaq shift
Market updates

kalkine: FTSE 350 firm Indivior PLC (LON:INDV) to leave London listing after Nasdaq shift

Highlights,Indivior PLC confirms it will delist from the London Stock Exchange,The company cites reduced complexity and stronger US trading volumes,Nasdaq now serves as Indivior’s sole primary listing,Pharmaceutical group Indivior PLC (LON:INDV), part of ...

Kalkine : Valterra Platinum’s London Debut and FTSE 100 Update
Mining Stocks

Kalkine : Valterra Platinum’s London Debut and FTSE 100 Update

Highlights,Valterra Platinum commenced trading in London following a demerger from Anglo American (LON:AAL),The new entity is listed outside the FTSE 100 and experienced initial share price volatility,Anglo American is restructuring to streamline its port...

Kalkine - FTSE 100: hVIVO (LON:HVO) Shares Drop Sharply Amid Increased Trading Activity
Healthcare Stocks

Kalkine - FTSE 100: hVIVO (LON:HVO) Shares Drop Sharply Amid Increased Trading Activity

Highlights,hVIVO (LON:HVO) experienced a significant drop in share price during recent trading activity, with trading volume rising substantially above average.,The company focuses on pharmaceutical services, primarily conducting human challenge trials fo...

Kalkine - FTSE 100: James Halstead’s Share Price Decline Amidst Modest Earnings Growth
Market updates

Kalkine - FTSE 100: James Halstead’s Share Price Decline Amidst Modest Earnings Growth

Highlights,James Halstead plc (LON:JHD) operates in the industrial sector and has experienced a long-term share price decline.,Despite the share price decline, the company’s earnings per share showed marginal growth over the five-year period.,The share pr...

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.